Russian biotech Biocad said it reached a deal with Sothema Labs of Morocco to produce biosimilars rituximab and bevacizumab, used to treat cancer. More: Russian biotech Biocad inks deal to manufacture biosimilars in Morocco Source: fierce
read moreAfter an analysis showed that Sanofi’s highly touted dengue vaccine could lead to more serious infections if used in the wrong setting, the company is requesting a label change that will likely lead to fewer eligible recipients. With the development, Sanofi
read moreNovartis has the option to sell its stake in its GlaxoSmithKline consumer health JV to its partner. But it doesn’t sound like that’s what the Swiss drugmaker’s plotting. More: Novartis 'clearly' plans to hang on to GSK consumer stake: analyst
read moreDrug prices took center stage at a contentious hearing for former Eli Lilly executive Alex Azar, who’s up for the top job at the Department of Health and Human Services. During the hearing, many senators grilled the nominee for his
read moreAllergan has been facing a lot of criticism of late, what with a sagging share price, pressure for a breakup and blowback on a maneuver to protect eye drug Restasis from generics. But it has gotten a little love from
read moreDublin, Ireland-based Alkermes has licensed ALKS 8700, a novel, oral, small drug molecule in Phase III development for relapsing forms of multiple sclerosis, to US biotech Biogen. More: Alkermes licences experimental MS therapy to Biogen Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals